Registro:

Referencias:

• Arzt, E., gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways (2001) Journal of Clinical Investigation, 108, pp. 1729-1733
• Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Interleukin involvement in anterior pituitary cell growth regulation: Effects of interleukin-2 and interleukin-6 (1993) Endocrinology, 132, pp. 459-467
• Sawada, T., Koike, K., Kanda, Y., Ikesami, H., Jikihara, T., Maeda, T., IL-6 stimulates cell proliferation of rat anterior pituitary clonal ceH lines in vitro (1995) Journal of Endocrinological Investigation, 18, pp. 83-90
• Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells (1997) Experimental and Clinical Endocrinology and Diabetes, 105, pp. 345-352
• Arzt, E., Paez Pereda, M., Perez Castro, C., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Frontiers in Neuroendocrinology, 20, pp. 71-95
• Renner, U., Pagotto, U., Arzt, E., Stalla, G.K., Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous function and growth: A review (1996) European Journal of Endocrinology, 135, pp. 515-532
• Paez Pereda, M., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Experimental and Clinical Endocrinology and Diabetes, 108, pp. 202-207
• Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., Denef, C., Production of IL-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106
• Vankelecom, H., Matthys, P., Van Damme, J., Heremans, H., Billiau, A., Denef, C., Immunocytochemical evidence that S-100 positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity (1993) Journal of Histochemistry and Cytochemistry, 41, pp. 151-156
• Inoue, K., Couch, E.F., Takano, K., Ogawa, S., The structure and function of folliculo-stellate cells in the anterior pituitary gland (1999) Archives of Histology and Cytology, 62, pp. 205-218
• Ferrara, N., Winer, J., Henzel, W.J., Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor (1992) PNAS, 89, pp. 698-702
• Perez Castro, C., Carbia Nagashima, A., Paez Pereda, M., Goldberg, V., Chervin, A., Largen, P., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753
• Lohrer, P., Gloddek, J., Carbia Nagashima, A., Korali, Z., Hopfner, U., Paez Pereda, M., Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway (2000) Endocrinology, 141, pp. 4457-4465
• Kiriyama, Y., Tsuchiya, K., Murakami, T., Satoh, K., Tokumitsu, Y., Calcitonin induces IL-6 production via both PKA and PKC pathways in the pituitary folliculo-stellate cell line (2001) Endocrinology, 142, pp. 3563-3569
• Ozawa, H., Ito, T., Ochiai, I., Kawata, M., Cellular localization and distribution of glucocorticoid receptor immunoreactivity and the expression of glucocorticoid receptor mRNA in rat pituitary gland. A combined double immunohistochemistry study and in situ hybridization histochemical analysis (1999) Cell and Tissue Research, 295, pp. 207-214
• Höfler, H., Walter, G.F., Denk, H., Immunohistochemistry of folliculo-stellate cells in normal human adenobypophyses and pituitary adenomas (1984) Acta Neuropathologica, 65, pp. 35-40
• Voit, D., Saeger, W., Lüdecke, D.K., Folliculo-stellate cells in pituitary adenomas of patients with acromegaly (1999) Pathological Research and Practice, 195, pp. 143-147
• Ueta, Y., Levy, A., Chowdrey, H.S., Lightman, S.L., S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas (1995) Journal of Neuroendocrinology, 7, pp. 467-474
• Jones, T.H., Daniels, M., James, R.A., Justice, S.K., McCorkle, R., Price, A., Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas (1994) Journal of Clinical Endocrinology and Metabolism, 78, pp. 180-187
• Rezai, A.R., Rezai, A., Martinez-Maza, O., Vander-Meyden, M., Weiss, M.H., Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors (1994) Journal of Neurooncology, 19, pp. 131-135
• Hanisch, A., Dieterich, K.D., Dietzmann, K., Lüdecke, K., Buchfelder, M., Fahlbusch, R., Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 4411-4414
• Jones, T.H., Kennedy, R.L., Justice, S.K., Price, A., Interleukin-1 stimulates the release of interleukin-6 from cultured human pituitary adenoma cells (1993) Acta Endocrinologica, 128, pp. 405-410
• Renner, U., Brockmeier, S., Strasburger, C.J., Lange, M., Schopohl, J., Müller, O.A., Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotrope adenoma cells: Interaction with GH-releasing hormone, thyrotropin-releasing hormone and octreotide (1994) Journal of Clinical Endocrinology and Metabolism, 78, pp. 1090-1096
• Lohrer, P., Gloddek, J., Hopfher, U., Losa, M., Uhl, E., Pagotto, U., Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro (2001) Neuroendocrinology, 74, pp. 95-105
• Asa, S.L., Ezzat, S., The cytogenesis and pathogenesis of pituitary adenomas (1998) Endocrine Reviews, 19, pp. 798-827
• Landis, C.A., Masters, S.B., Spada, A., Pace, A.M., Bourne, H.R., Vallar, L., GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours (1989) Nature, 340, pp. 692-696
• Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumours (2002) Nature Reviews, 2, pp. 836-849
• Perez Castro, C., Giacomini, D., Carbia Nagashima, A., Onofri, C., Graciarena, M., Kobayashi, K., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700
• Jones, T.H., Justice, S., Price, A., Chapman, K., Interleukin-6 secreting human pituitary adenomas in vitro (1991) Journal of Clinical Endocrinology and Metabolism, 73, pp. 207-209
• Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Harris, A.L., Wass, J.A., Angiogenesis in pituitary adenomas and the normal pituitary gland (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 1159-1162
• Popovic, V., Damjanovic, S., Micic, D., Manojlovic, D., Micic, J., Casanueva, F.F., Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumors (1993) Neuroendocrinology, 58, pp. 465-472
• Nakagawa, K., Akikawa, K., Marsubara, M., Kubo, M., Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly (1985) Journal of Clinical Endocrinology and Metabolism, 60, pp. 306-310
• Oosterom, R., Verleun, T., Lamberts, S.W., Human growth hormone-secreting adenoma cells in long-term culture: Effects of dexamethasone and growth hormone releasing factor (1984) Journal of Endocrinology, 100, pp. 353-360
• Oka, H., Jin, L., Reubi, J.C., Qian, X., Scheithauer, B.W., Fujii, K., Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas (1998) American Journal of Pathology, 153, pp. 1787-1796
• Bevan, J.S., Atkin, S.L., Atkinson, A.B., Bouloux, P.M., Hanna, F., Harris, P.E., Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 4554-4563
• Shupnik, M.A., Pitt, L.K., Soh, A.Y., Anderson, A., Lopes, M.B., Laws Jr., E.R., Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 3965-3972
• Jin, L., Qian, X., Kulig, E., Sanno, N., Scheithauer, B.W., Kovacs, K., Transforming growth factor-beta, transforming growth factor-β receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries (1997) American Journal of Pathology, 151, pp. 509-519
• Ezzat, S., Walpola, I.A., Ramyar, L., Smyth, H.S., Asa, S.L., Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells (1995) Journal of Clinical Endocrinology and Metabolism, 80, pp. 534-539
• Finley, E.L., Ramsdell, J.S., A transforming growth factor-alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation (1994) Endocrinology, 135, pp. 416-422
• LeRiche, V.K., Asa, S.L., Ezzat, S., Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 656-662

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------